INFLECTION MEDICINE
Live / Allowed — Notice of allowance issued (as of 14 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98656512
- Mark type
- Design + words
- Filed
- 19 Jul 2024
- Published for opposition
- 19 Aug 2025
- Attorney of record
- Kristin S. Cornuelle
Goods and services
- Class 005 — Pharmaceuticals: diagnostic tests consisting primarily of buffers and reagents for detecting genetic diseases and disorders
- Class 035 — Advertising and business services: New product commercialization of diagnostic products for genetic diseases and disorders; new product commercialization services of technology to improve clinical outcomes of individuals with genetic diseases and disorders; new product commercialization services of diagnostic products for identifying genetic diseases and disorders; new product commercialization services of technology that provides clinical guidance
- Class 042 — Scientific and technological services: Development of diagnostic apparatus and testing kits for genetic diseases and disorders; development of technology to improve clinical outcomes of individuals with genetic diseases and disorders; development of diagnostic apparatus for identifying genetic diseases and disorders; genome sequencing services in the nature of laboratory research; clinical research in the field of rapid whole genome sequencing test to enable the prevention, diagnosis and treatment of genetic diseases and disorders; development of technology that provides clinical guidance; platform as a service (PAAS) featuring computer software platform for data analysis, data management, data storage, data interpretation, and report generation, all in the field of genetics and genetic testing; clinical decision support technology in the nature of the provision of on-line non-downloadable software to assist in the translation of complex genomic sequencing for use in treatment plans by healthcare providers; providing genetic science information
- Class 044 — Medical, beauty and agricultural services: medical diagnostic and treatment services, namely, whole genome sequencing testing for treating of genetic disease and disorders; providing medical screening for detecting genetic diseases in newborns; medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by healthcare providers for the diagnosis and treatment of genetically-linked diseases and conditions; providing genetic counseling and providing information about genetic counseling; providing information about genetic testing for medical purposes
Owner
- Inflection Medicine, Inc., Boston, MA, US
- Inflection Medicine, Inc., Boston, MA, US
Prosecution history
- 29 Oct 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Aug 2025 — PUBLISHED FOR OPPOSITION
- 13 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jul 2025 — EXAMINER'S AMENDMENT ENTERED
- 11 Jul 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Jul 2025 — EXAMINERS AMENDMENT E-MAILED
- 11 Jul 2025 — EXAMINERS AMENDMENT -WRITTEN
- 04 Jun 2025 — ASSIGNED TO EXAMINER
- 31 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED